IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Arch Venture Management, LLC

Q2 2019 Holdings

Filed 2019-08-09 | 4 holdings | $96.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rubius Therapeutics IncCOM78116T103$41.2K2,618,35142.6%
Kura Oncology Inc(KURA)COM50127T109$26.7K1,356,30727.6%
Fate Therapeutics Inc(FATE)COM31189P102$19.8K973,19020.5%
Chiasma Inc(CHMA)COM16706W102$8.9K1,196,7769.3%